Publicacions en col·laboració amb investigadors/es de Yale University (34)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  4. Dietary intake of vitamin C and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project

    Gastric Cancer, Vol. 27, Núm. 3, pp. 461-472

  5. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

    Nature Communications, Vol. 15, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. MIF is a common genetic determinant of COVID-19 symptomatic infection and severity

    QJM : monthly journal of the Association of Physicians, Vol. 116, Núm. 3, pp. 205-212

  4. Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia

    iScience, Vol. 26, Núm. 8

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

    Schizophrenia Research, Vol. 227, pp. 10-17

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  5. Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic

    Expert Opinion on Investigational Drugs, Vol. 30, Núm. 4, pp. 377-388

2020

  1. Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis

    JAMA Oncology, Vol. 6, Núm. 11, pp. 1759-1765

  2. Polyphenol intake and gastric cancer risk: Findings from the stomach cancer pooling project (stop)

    Cancers, Vol. 12, Núm. 10, pp. 1-12

2018

  1. Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017

    AIDS Research and Human Retroviruses

2017

  1. The Association of Poor Academic Performance with Tic Disorders: A Longitudinal, Mainstream School-Based Population Study

    Neuroepidemiology, Vol. 48, Núm. 3-4, pp. 155-163